NFGH
KRTX

Nan Fung Group Holdings’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Nan Fung Group Holdings’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-225,688
Closed -$71.4M – 48
2023
Q4 		$71.4M Hold
225,688
– – 44.49% 1
2023
Q3 		$38.2M Hold
225,688
– – 30.9% 1
2023
Q2 		$48.9M Hold
225,688
– – 31.28% 1
2023
Q1 		$41M Hold
225,688
– – 27.89% 1
2022
Q4 		$44.3M Sell
225,688
-15,951
-7% -$3.42M 30.56% 1
2022
Q3 		$54.4M Buy
241,639
+15,951
+7% +$3.23M 34.69% 1
2022
Q2 		$28.6M Sell
225,688
-9,123
-4% -$1.05M 19.61% 2
2022
Q1 		$29.8M Hold
234,811
– – 14.12% 3
2021
Q4 		$30.8M Hold
234,811
– – 9.1% 4
2021
Q3 		$28.7M Hold
234,811
– – 9.19% 4
2021
Q2 		$26.8M Buy
+234,811
New +$27.4M 8.32% 3

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Nan Fung Group Holdings's KRTX Position: Q1 2024 in Review

Nan Fung Group Holdings sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 225,688 shares — an estimated $71.4M sold.

Nan Fung Group Holdings first reported a position in KRTX in Q2 2021 and held it in 11 quarters. The position peaked at $71.4M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Nan Fung Group Holdings reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nan Fung Group Holdings sold 225,688 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $71.4M.
  • Nan Fung Group Holdings first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
  • Nan Fung Group Holdings's Karuna Therapeutics, Inc. Common Stock position peaked at $71.4M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Nan Fung Group Holdings's 13F filing for Q1 2024, filed 14 May 2024.